Sexual functioning and body image of patients treated for ovarian cancer

被引:28
作者
Bukovic, Damir [1 ]
Silovski, Hrvoje [2 ]
Silovski, Tajana [3 ]
Hojsak, Iva [1 ]
Sakic, Kata [4 ]
Hrgovic, Zlatko [5 ,6 ]
机构
[1] Univ Zagreb, Univ Hosp Ctr, Dept Obstet & Gynecol, Zagreb, Croatia
[2] Univ Zagreb, Univ Hosp Ctr, Dept Surg, Zagreb, Croatia
[3] Univ Zagreb, Univ Hosp Tumors, Dept Clin Oncol, Zagreb, Croatia
[4] Univ Zagreb, Univ Hosp Ctr, Dept Anesthesiol Reanimatol & Intens Care, Zagreb, Croatia
[5] JJ Strossmeyer Univ, Dept Obstet & Gynecol, Osijek, Croatia
[6] Univ Hosp Osijek, Dept Obstet & Gynecol, Osijek, Croatia
关键词
ovarian cancer; sexual life; sexual functioning; body image;
D O I
10.1007/s11195-008-9074-z
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Aim The aim of the study was to determine differences in sexual functioning and body image of patients treated for ovarian cancer, depending on treatment modality: surgery, surgery in combination with chemotherapy or chemotherapy alone. Patients and Methods A total of 483 patients treated for ovarian cancer between 1995 and 2005 completed the questionnaire 2-6 months after finishing the treatment. Patients were divided into three groups. The first group consisted of 156 patients with early ovarian cancer, treated only surgically with hysterectomy and bilateral salphingoophorectomy. The second group consisted of 238 patients with advanced stages of ovarian cancer that were treated surgically in combination with chemotherapy. The third group consisted of 89 patients with advanced inoperable or metastatic ovarian cancer who were treated with chemotherapy alone. Results A significant number of patients in all three groups (group 1, 2 and 3) was satisfied with their sexual life before the treatment (74.36%, 69.33% and 71.91% respectively). Patients whose sexual life got worse after the treatment in all three study groups were numerous (group 1, 2 and 3-28.85%, 46.64% and 47.19%, respectively) and most intensively affected patients in groups 2 and 3 (p < 0.05). Most of the patients in group 1, 2 and 3 found their partners to have the same (33.33%, 34.87% and 44.94%, respectively) or even better (32.69%, 36.56% and 25.84%, respectively) attitude towards them, and described them as very supportive and tender. Most of the patients in all three treatment groups (51.28%, 54.62% and 52.81%, respectively, p > 0.05) found their body image different after the treatment, but not mutilated. Conclusion These findings support and extend previous reports of impaired sexual functioning among patients treated for ovarian cancer. Sexual functioning of the patients with more advanced disease stages, who were treated by combination of surgery and chemotherapy or chemotherapy alone, was more jeopardized than those with disease detected in an early stage and treated by surgery alone. Problems in sexual functioning appear to be related to the consequence of artificial menopause symptoms and the extent of disease.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 13 条
[1]   Sexual dysfunction in breast cancer survivors [J].
Bukovic, D ;
Fajdic, J ;
Hrgovic, Z ;
Kaufmann, M ;
Hojsak, I ;
Stanceric, T .
ONKOLOGIE, 2005, 28 (01) :29-34
[2]  
Bukovic D, 2003, COLLEGIUM ANTROPOL, V27, P173
[3]  
*CROAT NAT I PUBL, 2003, NEW CANC CAS CROAT
[4]  
FITCH MI, 2000, SEMIN ONCOL NURS S1, V19, P40
[5]   Constructions of sexuality and intimacy after cancer: Patient and health professional perspectives [J].
Hordern, Amanda Jane ;
Street, Annette F. .
SOCIAL SCIENCE & MEDICINE, 2007, 64 (08) :1704-1718
[6]   Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues [J].
Stead, ML ;
Brown, JM ;
Fallowfield, L ;
Selby, P .
BRITISH JOURNAL OF CANCER, 2003, 88 (05) :666-671
[7]   Sexual activity questionnaires in clinical trials: acceptability to patients with gynaecological disorders [J].
Stead, ML ;
Crocombe, WD ;
Fallowfield, LJ ;
Selby, P ;
Perren, TJ ;
Garry, R ;
Brown, JM .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (01) :50-54
[8]   Sexual function after treatment for gynecological malignancy [J].
Stead, ML .
CURRENT OPINION IN ONCOLOGY, 2004, 16 (05) :492-495
[9]   What doesn't kill you makes you stronger: An ovarian cancer survivor survey [J].
Stewart, DE ;
Wong, F ;
Duff, S ;
Melancon, CH ;
Cheung, AM .
GYNECOLOGIC ONCOLOGY, 2001, 83 (03) :537-542
[10]   Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer [J].
Sun, CC ;
Bodurka, DC ;
Weaver, CB ;
Rasu, R ;
Wolf, JK ;
Bevers, MW ;
Smith, JA ;
Wharton, JT ;
Rubenstein, EB .
SUPPORTIVE CARE IN CANCER, 2005, 13 (04) :219-227